Редакционная политика

Тематика журнала

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

●      DNA/protein engineering and processing
●      Synthetic biotechnology
●      Omics (genomics, proteomics, metabolomics and systems biology)
●      Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
●      Drug delivery and targeting
●      Nanobiotechnology
●      Molecular pharmaceutics and molecular pharmacology
●      Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
●      Pharmacokinetics and pharmacodynamics
●      Applied Microbiology
●      Bioinformatics (computational biopharmaceutics and modeling)
●      Environmental biotechnology
●      Regenerative medicine (stem cells, tissue engineering and biomaterials)
●      Translational immunology (cell therapies, antibody engineering, xenotransplantation)
●      Industrial bioprocesses for drug production and development
●      Biosafety
●      Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Разделы и направления

Biotechnology

Рецензирование

Bentham Science Publishers follows the double-blind peer review procedure for submissions of all manuscripts to its journals.

All submitted articles are subjected to an extensive peer review in consultation with members of the journal’s editorial board and independent external referees (usually three reviewers). All manuscripts/chapters are assessed rapidly and the decision based on all the peer reviewers' comments, taken by the journal’s Editor-in-Chief, is then conveyed to the author(s).

Submissions from the Editor-in-Chief/Co-Editor/Editorial Board Members will undergo independent peer review and will be submitted to another Editor for his decision on acceptance. For further details, please visit complete guidelines at: https://benthamscience.com/pages/peer-reviews

Use of Generative AI and AI-assisted Technologies in the Peer Review Process

Since the use of AI technology has increased, it has brought its own challenges regarding the originality of the review of submitted manuscripts. Bentham Science has been striving to improve its policies accordingly. With time, we will continue to update our policies to support our reviewers, authors, and editors.

The quality of the peer review of submitted articles has been our top priority. The reviewers are advised not to use AI technologies or any other related assisting resources to generate review reports that could compromise the integrity and confidentiality of the reports.

The full Reviewer Guidelines are available here: https://www.benthamscience.com/journal/30/guideline-for-reviewers